Bionaire Technology

Shanghai Bionaire Biotech. Co., Ltd. was founded in 2017 by a team lead by Dr. Mei Jun, an oversea scholar from the United States, and a doctoral tutor at Shanghai Jiao Tong University School of Medicine. The Bionaire with Suzhou Hygia Biotechnology Co., Ltd., and Jiangsu Panacea Biotechnology Co., Ltd. form a group structure integrating R&D, production and sales.

In vitro diagnostics: mainly relying on the company's many original invention technologies, providing products for the clinical demands, such as accompanying diagnosis products for tumor targeted therapy , rapid tumor screening products, and rapid detection of pathogenic microorganisms.

Health service: beginning with accompanying diagnosis products for tumor target therapy, it integrates the upstream and downstream industrial chain to build a health service center serving high-end physical examination and tumor rehabilitation patients.

COVID-19 Test Kits & Protective Items against Novel Coronavirus (SARS-CoV-2)